906
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease: preparation, feasibility and efficiency – preliminary results

, , , , , , & show all
Pages 895-904 | Received 29 Dec 2016, Accepted 16 Apr 2017, Published online: 05 May 2017

References

  • Reiners C, Wegscheider K, Schicha H, et al. (2004). Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926–32.
  • Papi G, Corsello SM, Pontecorvi A. (2014). Clinical concepts on thyroid emergencies. Front Endocrinol 5:102.
  • Yano Y, Sugino K, Akaishi J, et al. (2011). Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy. Ann Nucl Med 25:749–54.
  • Meier DABD, Becker DV, Clarke SEM, et al. (2016). Procedure guideline for therapy of thyroid disease with 131Iodine. J Nucl Med 43:856–61.
  • Bachmann J, Kobe C, Bor S, et al. (2009). Radioiodine therapy for thyroid volume reduction of large goitres. Nucl Med Commun 30:466–71.
  • Mishra A, Sabaretnam M, Chand G, et al. (2013). Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study. World J Surg 37:2322–9.
  • Hegedüs L. (2009). A new nonsurgical therapy option for benign thyroid nodules? Nat Rev/Endocrinol 5:476–78.
  • Mauri G, Sconfienza LM. (2017). Percutaneous ablation holds the potential to substitute for surgery as first choice treatment for symptomatic benign thyroid nodules. Int J Hypertherm 33:301–2.
  • Chianelli M, Bizzarri G, Todino V, et al. (2014). Laser ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter. J Clin Endocrinol Metabol 99:E1283–6.
  • Zingrillo M, Modoni S, Conte M, et al. (2003). Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules. J Nucl Med 44:207–10.
  • Vogl TJ, Mack M, Eichler K, et al. (2011). Interventionelle Thermoablation von malignen Lebertumoren und Lebermetastasen: Vergleich von Radiofrequenzablation (RFA), laserinduzierter Thermotherapie (LITT) und Mikrowellenablation (MWA). Hessisches Ärzteblatt 10:606–15.
  • De Bernardi IC, Floridi C, Muollo A, et al. (2014). Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. La Radiol Med 119:512–20.
  • Heck K, Happel C, Grunwald F, Korkusuz H. (2015). Percutaneous microwave ablation of thyroid nodules: effects on thyroid function and antibodies. Int J Hypertherm 31:560–7.
  • Kohlhase KD, Korkusuz Y, Groner D, et al. (2016). Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hypertherm 32:511–16.
  • Mader OM, Tanha NF, Mader A, et al. (2017). Comparative study evaluating the efficiency of cooled and uncooled single-treatment MWA in thyroid nodules after a 3-month follow up. Eur J Radiol Open 4:4–8.
  • Korkusuz Y, Mader OM, Kromen W, et al. (2017). Cooled microwave ablation of thyroid nodules: initial experience. Eur J Radiol 85:2127–32.
  • Happel C, Korkusuz H, Kranert WT, Grünwald F. (2014). Combination of ultrasound guided percutaneous microwave ablation and radioiodine therapy for treatment of hyper- and hypofunctioning thyroid nodules. Nuklearmed Nucl Med 53:N48–9.
  • Reiners C, Dietlein M, Luster M. (2015). Stationäre nuklearmedizinische Therapie 2010 bis 2012 in Deutschland. Nuklearmed Nucl Med 54:61–8.
  • Verburg FA. (2015). Is thyroid surgery performed too often in Germany? Nuklearmed Nucl Med 54:101–5.
  • Aizer AA, Chen MH, Parekh A, et al. (2014). Refusal of curative radiation therapy and surgery among patients with cancer. Int J Radiat Oncol Biol Phys 89:756–64.
  • Freudenberg LS, Beyer T, Muller SP, et al. (2006). Evil radioactivity. Subjective perception of radioactivity in patients with thyroid disease prior to treatment with radioiodine. Nuklearmed Nucl Med 45:229–34.
  • von Muller F, Happel C, Reinhardt J, et al. (2014). Evaluation of fear of radiation and isolation before and after radioiodine therapy. Thyroid 24:1151–5.
  • Freudenberg L, Muller S, Beyer T, Bockisch A. (2009). Subjective perception of radioactivity – no change post successful treatment with radioiodine. Nuklearmed Nucl Med 48:84–8.
  • Freudenberg LS, Beyer T. (2011). Subjective perception of radiation risk. J Nucl Med 52 Suppl 2:29S–35S.
  • Dietlein M. (2007). Procedure guideline for radioiodine test (Version 3). Nuklearmed Nucl Med 5:198–202.
  • Marinelli LD. (1949). Dosage determination in the use of radioactive isotopes. J Clin Investig 28:1271–80.
  • Goldberg SN, Gazelle GS. (2001). Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepato-gastroenterology 48:359–67.
  • Simon CJ, Dupuy DE, Mayo-Smith WW. (2005). Microwave ablation: principles and applications. Radiographics 25 Suppl 1:S69–S83.
  • Bernardi S, Dobrinja C, Fabris B, et al. (2014). Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014:934595.
  • Che Y, Jin S, Shi C, et al. (2015). Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol 36:1321–5.
  • Dong Gyu Na JHL. (2012). Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 13:117–25.
  • Huh JY, Baek JH, Choi H, et al. (2012). Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session – prospective randomized study. Radiology 263:909–16.
  • Jeong WK, Baek JH, Rhim H, et al. (2008). Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–50.
  • Ha JH, Ba JH, Lee JH. (2011). The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes 18:310–14.
  • Park KW, Shin JH, Han BK, et al. (2011). Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol 18:2564–8.
  • Korkusuz H, Happel C, Koch DA, Gruenwald F. (2016). Combination of ultrasound-guided percutaneous microwave ablation and radioiodine therapy in benign thyroid disease: a 3-month follow-up study. RoFo: Fortschritte Auf Dem Gebiete Der Rontgenstrahlen 188:60–8.
  • Ferreira MC, Piaia C, Cadore AC. (2016). Percutaneous ethanol injection versus conservative treatment for benign cystic and mixed thyroid nodules. Arch Endocrinol Metabol 60:211–16.
  • Reverter JL, Alonso N, Avila M, et al. (2015). Evaluation of efficacy, safety, pain perception and health-related quality of life of percutaneous ethanol injection as first-line treatment in symptomatic thyroid cysts. BMC Endocr Disord 15:73.
  • Sung JY, Baek JH, Kim KS, et al. (2013). Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 269:293–300.
  • Mauz PS, Stiegler M, Holderried M, Brosch S. (2005). Complications of ultrasound guided percutaneous ethanol injection therapy of the thyroid and parathyroid glands. Ultraschall Med 26:142–5.
  • Mack MG, Lehnert T, Eichler K, Vogl TJ. (2005). MR-guided laser ablation. Magn Reson Imaging Clin N Am 13:583–94.
  • Vogl TJ, Naguib NN, Lehnert T, Nour-Eldin NE. (2011). Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations–review article. Eur J Radiol 77:346–57.
  • Atsumi H, Matsumae M. (2005). Laser interstitial thermo therapy (LITT) for brain tumors. Nihon Rinsho Japan J Clin Med 63Suppl 9:495–8.
  • Pacella CM, Mauri G, Achille G, et al. (2015). Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metabol 100:3903–10.
  • Negro R, Salem TM, Greco G. (2016). Laser ablation is more effective for spongiform than solid thyroid nodules. A 4-year retrospective follow-up study. Int J Hypertherm 32:822–8.
  • Mauri G, Cova L, Monaco CG, et al. (2017). Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hypertherm 33:295–9.
  • Korkusuz H, Happel C, Heck K, et al. (2014). Percutaneous thermal microwave ablation of thyroid nodules. Preparation, feasibility, efficiency. Nuklearmed Nucl Med 53:123–30.
  • Korkusuz H, Nimsdorf F, Happel C, et al. (2015). Percutaneous microwave ablation of benign thyroid nodules. Functional imaging in comparison to nodular volume reduction at a 3-month follow-up. Nuklearmed Nucl Med 54:13–19.
  • Warmuth M. (2012). Radiofrequenzablation bei benignen und malignen Veraenderungen endokriner Organe (Schilddruese und Nebenniere). Ludwig Boltzmann Institut Fuer Health Technology Assessment (LBI-HTA) 56:1–48.
  • Li XL, Xu HX, Lu F, et al. (2016). Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br J Radiol 89:20150858.
  • Goldberg SN, Gazelle GS, Compton CC, et al. (2000). Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–63.
  • Fuller CW, Nguyen SA, Lohia S, Gillespie MB. (2014). Radiofrequency ablation for treatment of benign thyroid nodules: systematic review. Laryngoscope 124:346–53.
  • Baek JH, Kim YS, Lee D, et al. (2010). Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 194:1137–42.
  • Young-Sun Kim HREA. (2006). Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–7.
  • Baek JH, Jeong HJ, Kim YS, et al. (2008). Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 18:675–6.
  • Spiezia S, Garberoglio R, Milone F, et al. (2009). Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 19:219–25.
  • Ha EJ, Baek JH, Kim KW, et al. (2015). Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and Bayesian network meta-analysis. J Clin Endocrinol Metabol 100:1903–11.
  • Goldberg SN. (2001). Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 13:129–47.
  • Shin JH, Beak JH, Ha EJ, Lee JH. (2012). Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol 2012:7 pages.
  • Yu J, Liang P, Yu X, et al. (2011). A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 79:124–30.
  • Wright AS, Sampson LA, Warner TF, et al. (2005). Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236:132–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.